IBDEI1NU ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,26513,1,3,0)
 ;;=3^ENVIRONM INTERV FOR MED MGMT W/ EMPLOYER/AGENCY/INSTITUTION
 ;;^UTILITY(U,$J,358.3,26514,0)
 ;;=90887^^108^1248^12^^^^1
 ;;^UTILITY(U,$J,358.3,26514,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,26514,1,2,0)
 ;;=2^90887
 ;;^UTILITY(U,$J,358.3,26514,1,3,0)
 ;;=3^CONSULTATION W/ FAMILY FOR INTERP/EXPLAN EXAM/TEST RESULTS
 ;;^UTILITY(U,$J,358.3,26515,0)
 ;;=96105^^108^1248^7^^^^1
 ;;^UTILITY(U,$J,358.3,26515,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,26515,1,2,0)
 ;;=2^96105
 ;;^UTILITY(U,$J,358.3,26515,1,3,0)
 ;;=3^ASSESSMENT OF APHASIA W/ INTERP & RPT,PER HR BY PHD/PHYS
 ;;^UTILITY(U,$J,358.3,26516,0)
 ;;=96110^^108^1248^15^^^^1
 ;;^UTILITY(U,$J,358.3,26516,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,26516,1,2,0)
 ;;=2^96110
 ;;^UTILITY(U,$J,358.3,26516,1,3,0)
 ;;=3^DEVELOPMENTAL SCREEN w/ SCORE & DOCUM,BY PHD/PHYS
 ;;^UTILITY(U,$J,358.3,26517,0)
 ;;=96116^^108^1248^34^^^^1
 ;;^UTILITY(U,$J,358.3,26517,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,26517,1,2,0)
 ;;=2^96116
 ;;^UTILITY(U,$J,358.3,26517,1,3,0)
 ;;=3^NEUROBEHAV STATUS EXAM,PSYCH/PHYS PER HR
 ;;^UTILITY(U,$J,358.3,26518,0)
 ;;=97537^^108^1248^11^^^^1
 ;;^UTILITY(U,$J,358.3,26518,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,26518,1,2,0)
 ;;=2^97537
 ;;^UTILITY(U,$J,358.3,26518,1,3,0)
 ;;=3^COMMUNITY/WORK REINTEGRATION EA 15 MIN,BY PHD/PHYS
 ;;^UTILITY(U,$J,358.3,26519,0)
 ;;=97545^^108^1248^64^^^^1
 ;;^UTILITY(U,$J,358.3,26519,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,26519,1,2,0)
 ;;=2^97545
 ;;^UTILITY(U,$J,358.3,26519,1,3,0)
 ;;=3^WORK THERAPY,2 HRS
 ;;^UTILITY(U,$J,358.3,26520,0)
 ;;=97546^^108^1248^65^^^^1
 ;;^UTILITY(U,$J,358.3,26520,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,26520,1,2,0)
 ;;=2^97546
 ;;^UTILITY(U,$J,358.3,26520,1,3,0)
 ;;=3^WORK THERAPY,EA ADDL HR
 ;;^UTILITY(U,$J,358.3,26521,0)
 ;;=H0004^^108^1248^28^^^^1
 ;;^UTILITY(U,$J,358.3,26521,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,26521,1,2,0)
 ;;=2^H0004
 ;;^UTILITY(U,$J,358.3,26521,1,3,0)
 ;;=3^INDIV COUNSELING & THERAPY,EA 15MIN
 ;;^UTILITY(U,$J,358.3,26522,0)
 ;;=H0005^^108^1248^3^^^^1
 ;;^UTILITY(U,$J,358.3,26522,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,26522,1,2,0)
 ;;=2^H0005
 ;;^UTILITY(U,$J,358.3,26522,1,3,0)
 ;;=3^ADDICTIONS GRP COUNSEL BY CLINICIAN
 ;;^UTILITY(U,$J,358.3,26523,0)
 ;;=H0031^^108^1248^31^^^^1
 ;;^UTILITY(U,$J,358.3,26523,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,26523,1,2,0)
 ;;=2^H0031
 ;;^UTILITY(U,$J,358.3,26523,1,3,0)
 ;;=3^MH ASSESS BY NON-PHYS
 ;;^UTILITY(U,$J,358.3,26524,0)
 ;;=H0034^^108^1248^30^^^^1
 ;;^UTILITY(U,$J,358.3,26524,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,26524,1,2,0)
 ;;=2^H0034
 ;;^UTILITY(U,$J,358.3,26524,1,3,0)
 ;;=3^MED TRAINING/SUPPORT,PER 15 MIN
 ;;^UTILITY(U,$J,358.3,26525,0)
 ;;=H0046^^108^1248^43^^^^1
 ;;^UTILITY(U,$J,358.3,26525,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,26525,1,2,0)
 ;;=2^H0046
 ;;^UTILITY(U,$J,358.3,26525,1,3,0)
 ;;=3^PTSD GRP/MH SVCE NOS
 ;;^UTILITY(U,$J,358.3,26526,0)
 ;;=H0048^^108^1248^62^^^^1
 ;;^UTILITY(U,$J,358.3,26526,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,26526,1,2,0)
 ;;=2^H0048
 ;;^UTILITY(U,$J,358.3,26526,1,3,0)
 ;;=3^URINE COLLECTION AND HANDLING
 ;;^UTILITY(U,$J,358.3,26527,0)
 ;;=H0025^^108^1248^2^^^^1
 ;;^UTILITY(U,$J,358.3,26527,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,26527,1,2,0)
 ;;=2^H0025
 ;;^UTILITY(U,$J,358.3,26527,1,3,0)
 ;;=3^ADDICTION HLTH PREVENTION EDUC SERVICE
